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outward displacement of the anulus into the right ventri-
cle. Direct closure of the defect combined with plication
of the sinus, as described in our article (J Thorac Cardio-
vasc Surg 1997;113:253-61), corrects these abnormalities.
In contrast, insertion of patches will add to the redundant
tissue and does not restore the position of the aortic
anulus and cusp to treat or prevent subsequent aortic
regurgitation. With regard to the choice of a transaortic or
transpulmonary approach, we believe that the transaortic
approach offers many advantages, which include the ca-
pacity to plicate the thin part of the dilated sinus and
accurately attach the crest of the ventricular septum and
anulus to the edge of the normal aortic media, below the
coronary orifice. In addition, the aortic valve can be
assessed and any additional procedures to restore compe-
tence can be considered. In this regard, we agree fully with
Hisatomi and colleagues that earlier operation obviates
the need for aortic valvuloplasty and that maneuvers
designed to avoid direct operations on the cusp are
preferable. With the widespread use of echocardiography
and the distinct and easily detectable echocardiographic
features of the syndrome, it should be possible to diagnose
and correct the defect before the development of second-
ary changes in the cusps.
Professor Sir Magdi H. Yacoub
Cardiothoracic Surgeon
Imperial College School of Medicine
National Heart & Lung Institute
Dovehouse St.
London SW3 6LY, United Kingdom
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Thoracic duct ligation for chylopericardium
To the Editor:
In the August 1997 issue of the Journal (1997;114:299),
Yu¨ksel and associates stated “no such approach [thora-
cotomy for ligation of the thoracic duct] to isolated
primary chylopericardium has been described in the liter-
ature.” My colleagues and I1 described such an approach
in 1990 in a case report published in the Journal of
Pediatric Surgery. A child with primary chylopericardium
had initial left thoracotomy and pericardial window, fol-
lowed by a no-fat diet. This was unsuccessful (recurrent
chylopericardium). Two weeks later he had a right thora-
cotomy with ligation of the thoracic duct. This was suc-
cessful, and on long-term follow-up he has had no recur-
rence of the chylopericardium.
Carl L. Backer, MD
Division of Cardiothoracic Surgery
Children’s Memorial Hospital
2300 Children’s Plaza
Box 22
Chicago, IL 60614-3318
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Reply to the Editor:
In the article by Musemeche and associates,1 they
reported the case of a 12-year-old boy with primary
chylopericardium who was unresponsive to initial treat-
ment with left thoracotomy and pericardial window fol-
lowed by a no-fat diet. Two weeks later, because of
recurrence of the chylopericardium, they performed a
right thoracotomy with ligation of the thoracic duct.
In our letter to the Editor,2 we discussed a patient with
a chylopericardium who was treated by thoracoscopic
thoracic duct ligation and pericardial fenestration. We
think that Dr. Backer misunderstands what we meant. The
sentence “no such approach to isolated chylopericardium
has been described in the literature” did not mean that
thoracotomy for ligation of the thoracic duct had not been
described for the treatment of primary chylopericardium.
What we would like to state is that there is no universally
accepted method of managing primary chylopericardium,
whereas there is an accepted algorithm for the therapy of
chylothorax3 (chest tube insertion, a medium-chain tri-
glyceride diet for 2 weeks, and then surgery). On the other
hand, we agree with Dr. Backer that early thoracic duct
ligation combined with partial pericardiectomy is the
treatment of choice for primary chylopericardium.
Mustafa Yu¨ksel, MD
Bedrettin Yildizeli, MD
Department of Thoracic Surgery
Mamara Univeristy Hospital
PK 97 Acibadem
Istanbul, Turkey
R E F E R E N C E S
1. Musemeche CA, Riveron FA, Backer CL, Zales VR, Idriss FS.
Massive primary chylopericardium: a case report. J Pediatr
Surg 1990;25:840-2.
2. Yu¨ksel M, Yildizeli B, Zonu¨zi F, Batirel HF. Isolated primary
chylopericardium [letter]. J Thorac Cardiovasc Surg 1997:114:
299.
3. Malthaner RA, McKneally. Anatomy of the thoracic duct and
chylothorax. In: Pearson FG, Deslauriers J, Ginsberg RJ, et al,
editors. Thoracic surgery. 1st ed. New York: Churchill Living-
stone; 1995. p. 1069-81.
12/8/87533
Aortopulmonary paraganglioma: An overview after
five years
To the Editor:
In December 1993, we published a case report in this
Journal1 concerning a paraganglioma in the aortic arch of
a 64-year-old woman. The operation was performed on
June 21, 1991. In this report we specifically emphasized
the importance of conventional angiography over aortog-
raphy by digital substraction for making an early diagno-
sis.
Later, in a letter to the Editor, Lacquet2 suggested a list
of recommendations and comments we should follow in
diagnosis of possible new locations of paraganglioma or
Carney’s triad.3
Our patient has been seen annually in our center and
has had no symptoms indicative of any complications. In
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October 1996, more than 5 years after the operation,
routine radiographs confirmed her satisfactory condition,
and the most recent computed tomographic scan ruled out
any complications. The appearance of the aortic arch on
the computed tomographic scans before and after resec-
tion (Figs. 1 and 2) revealed a conservative aortic anatomy
with no local complications.
In the absence of local relapse and without any data
indicative of other tumors, we recommended less frequent
check-ups and arranged an appointment for 2 years after
the last examination. We consider that the follow-up
period (of more than 5 years) is sufficient to consider that
the risk of new tumors associated with the paraganglioma
has now been considerably reduced.
J. Castan˜on, MDa
S. Blanco, MDb
M. Gil-Aguad, MDa
A. Alswies, MDa
F. O’Connor, MDa
A. J. Torres, MDb
Departments of Cardiac Surgerya and Thoracic Surgeryb
Cardiac Surgery
Hospital Universitario “San Carlos”
Madrid, Spain
Fig 1. Chest scan before the operation.
Fig 2. Chest scan 5 years after the operation.
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I, too, can top this
To the Editor:
I enjoyed Dr. Oury’s “Can You Top This?” letter to the
Editor (J Thorac Cardiovasc Surg 1997;114:147), and I
rise to the challenge. Currently I am aware of two of our
patients who underwent mitral valve replacement on May
11, 1976, and April 8, 1977, respectively.
The transthoracic echocardiogram on the first patient
revealed a mean transvalvular gradient of 6 mm Hg with a
calculated mitral valve area of 1.5 to 1.6 cm2. The latter
patient has only Doppler evidence of mild mitral regurgi-
tation; however, no murmur is audible. Both echocardio-
grams were performed in 1995.
The first patient died of chronic obstructive pulmonary
disease and liver failure on March 29, 1997 (20 years and
348 days after mitral valve replacement), and the second
patient remains alive and well 20 years and 203 days after
mitral valve replacement.
I do believe it is even more impressive that a porcine
mitral valve lasted this long, particularly in view of con-
tinued systolic trauma with cardiac contraction.
Marshall D. Goldin, MD
Cardiovascular Surgical Associates, PC
1725 West Harrison St., Suite 1156
Chicago, IL 60612
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We did top this!
To the Editor:
In response to the letter from Dr. James H. Oury, “Can
You Top This?”1 we wish to submit the following as the
longest recorded functioning bioprosthesis.
On November 4, 1997, I (G.P.) explanted a 27 mm
Hancock standard aortic bioprosthesis, model 242
(Medtronic, Inc., Minneapolis, Minn.), from a 76-year-old
man who had congestive heart failure resulting from
structural deterioration and severe aortic insufficiency.
The valve had been implanted on December 9, 1976, by
Dr. J. C. Davila at Henry Ford Hospital. The duration of
implantation for this valve, therefore, was 20 years and
321 days, thus exceeding that of Dr. Oury’s patient by 1
year, 63 days. Because of the patient’s present age, it was
replaced with another bioprosthesis.
Grossly, two of the three leaflets had minor calcifica-
tions but seemed quite intact, not unlike the valve de-
scribed by Dr. Oury. The right coronary cusp was torn
along both commissural attachments. The valve was sent
to Medtronic for further analysis. Along with the right
cusp tear, they found that the right and noncoronary cusps
were stiff because of visible mineralization. Radiographs
showed moderate mineralization of all the commissures
that extended onto the belly of the right cusp and non-
coronary cusp near the point of coaptation. The left cusp
was flexible and the noncoronary left commissure was
intact.
We thereby repeat the previous challenge: Can you top
this?
Gaetano Paone, MD
Cardiac & Thoracic Surgery
Henry Ford Hospital
Detroit, Mich.
Dave Myers
Associate Technical Fellow
Medtronic Heart Valves
18011 South Mitchell Ave.
Irvine, CA 92714
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